APOTEX CORP. for APOTEX CORP.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 1145, Patent Reform Act of 2007, Section 12 Inequitable Conduct
Foreign entity interest: Apotex Holdings, Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop. manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | — |
Medicare/Medicaid MMM
Centers for Medicare and Medicaid Services Rule 2238-P concerning Medicaid Drug Reimbursement HR 3700 & S 1951, Fair Medicaid Drug Pricing Act
Foreign entity interest: Apotex Holdings, Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop. manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | — |
Pharmacy PHA
S. 316, the Preserve Access to Affordable Pharmaceuticals Act HR 1902, the Protecting Consumer Access to Generic Drugs Act HR 1038, the Access to Life Savings Medicine Act HR 5629, the Pathway for Biosimilars Act S. 1695, the Biologics Price Competition and Innovation Act HR 5829, the Safeguarding America's Pharmaceuticals Act HR 3610, the Food and Drug Import Safety Act, Section 4 User Fees Regarding Drug Safety PL 110-85, the Foord and Drug Amendments Act of 2007, Section 914, Citizen Petition and petition for stay of agency action PL 110-85, the Food and Drug Amendments Act of 2007. Title VIII, Clinical Trial Databases HR 6432, Animal Drug User Fee Amendments of 2008, Section 301, Consideration of Certain Petitions Combating anti-generic substitution legislation in the states Abbreviated New Drug Application No. 76-396 for calcitonin salmon nasal spray
Foreign entity interest: Apotex Holdings, Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop. manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.